Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

NEOGENOMICS LABORATORIES INC

NPI: 1205063294 · RAMSEY, NJ 07446 · Clinical Medical Laboratory · NPI assigned 06/17/2009

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official SHERMAN, JEFFREY controls 12+ related entities in our dataset. Read more

$3.05M
Total Medicaid Paid
86,661
Total Claims
66,285
Beneficiaries
31
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSHERMAN, JEFFREY (CHIEF FINANCIAL OFFICER)
NPI Enumeration Date06/17/2009

Related Entities

Other providers sharing the same authorized official: SHERMAN, JEFFREY

ProviderCityStateTotal Paid
NEOGENOMICS LABORATORIES INC ALISO VIEJO CA $21.49M
NEOGENOMICS LABORATORIES INC JUNO BEACH FL $4.73M
NEOGENOMICS LABORATORIES INC FORT MYERS FL $2.33M
NEOGENOMICS LABORATORIES INC CARLSBAD CA $1.42M
NEOGENOMICS LABORATORIES INC HOUSTON TX $433K
NEOGENOMICS LABORATORIES INC FRESNO CA $394K
NEOGENOMICS LABORATORIES INC NASHVILLE TN $23K
NEOGENOMICS LABORATORIES INC SIERRA MADRE CA $15K
NEOGENOMICS LABORATORIES INC TEMPLE TERRACE FL $12K
NEOGENOMICS LABORATORIES INC HOUSTON TX $2K
NEOGENOMICS LABORATORIES INC TROY MI $784.07
NEOGENOMICS LABORATORIES INC SCOTTSDALE AZ $704.18

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,857 $85K
2019 6,170 $121K
2020 19,538 $980K
2021 25,855 $783K
2022 17,556 $557K
2023 7,705 $248K
2024 6,980 $273K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 28,093 18,913 $1.63M
88305 Level IV - Surgical pathology, gross and microscopic examination 20,096 16,634 $692K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 15,336 10,221 $235K
88342 9,400 8,126 $181K
88377 470 386 $72K
88185 166 159 $48K
88312 2,464 2,322 $21K
88313 2,708 2,561 $20K
88189 995 959 $19K
88341 514 452 $14K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 117 96 $13K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 709 709 $13K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 381 335 $13K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 754 753 $12K
88304 772 589 $11K
88360 368 321 $8K
88120 14 14 $7K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 378 377 $6K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 381 380 $6K
81513 179 178 $6K
88307 40 40 $4K
87481 182 182 $4K
88184 165 159 $3K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 194 193 $3K
88108 107 93 $1K
87563 56 56 $741.66
88368 13 12 $704.51
88237 12 12 $570.09
88302 16 16 $414.63
85097 13 13 $140.94
99080 1,568 1,024 $0.00